These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 21540026)
41. Immunohistochemical Profiling of Endometrial Serous Carcinoma. Chen W; Husain A; Nelson GS; Rambau PF; Liu S; Lee CH; Lee S; Duggan MA; Köbel M Int J Gynecol Pathol; 2017 Mar; 36(2):128-139. PubMed ID: 27167671 [TBL] [Abstract][Full Text] [Related]
42. Apoptosis and the expression of Bcl-2 and Bax in patients with endometrioid, clear cell, and serous carcinomas of the uterine endometrium. Kokawa K; Shikone T; Otani T; Nishiyama R; Ishii Y; Yagi S; Yamoto M Gynecol Oncol; 2001 May; 81(2):178-83. PubMed ID: 11330946 [TBL] [Abstract][Full Text] [Related]
43. Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling. Wong YF; Cheung TH; Lo KW; Yim SF; Siu NS; Chan SC; Ho TW; Wong KW; Yu MY; Wang VW; Li C; Gardner GJ; Bonome T; Johnson WB; Smith DI; Chung TK; Birrer MJ Oncogene; 2007 Mar; 26(13):1971-82. PubMed ID: 17043662 [TBL] [Abstract][Full Text] [Related]
44. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer. Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232 [TBL] [Abstract][Full Text] [Related]
45. Gene expression profiles in stage I uterine serous carcinoma in comparison to grade 3 and grade 1 stage I endometrioid adenocarcinoma. Mhawech-Fauceglia P; Wang D; Kesterson J; Syriac S; Clark K; Frederick PJ; Lele S; Liu S PLoS One; 2011 Mar; 6(3):e18066. PubMed ID: 21448288 [TBL] [Abstract][Full Text] [Related]
46. Gene expression profiling in human endometrial cancer tissue samples: utility and diagnostic value. Smid-Koopman E; Blok LJ; Helmerhorst TJ; Chadha-Ajwani S; Burger CW; Brinkmann AO; Huikeshoven FJ Gynecol Oncol; 2004 May; 93(2):292-300. PubMed ID: 15099936 [TBL] [Abstract][Full Text] [Related]
47. The use of P53, PTEN, and C-erbB-2 to differentiate uterine serous papillary carcinoma from endometrioid endometrial carcinoma. Macwhinnie N; Monaghan H Int J Gynecol Cancer; 2004; 14(5):938-46. PubMed ID: 15361207 [TBL] [Abstract][Full Text] [Related]
48. HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical features. Ota T; Gilks CB; Longacre T; Leung PC; Auersperg N Reprod Sci; 2007 Sep; 14(6):605-14. PubMed ID: 17959889 [TBL] [Abstract][Full Text] [Related]
49. [Application of immunohistochemistry in differential diagnosis of endometrial carcinoma]. Wu HW; Liu TH Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):784-8. PubMed ID: 23302346 [No Abstract] [Full Text] [Related]
50. Haptoglobin expression in endometrioid adenocarcinoma of the uterus. Nabli H; Tuller E; Sharpe-Timms KL Reprod Sci; 2010 Jan; 17(1):47-55. PubMed ID: 19801537 [TBL] [Abstract][Full Text] [Related]
51. Discriminating miRNA Profiles between Endometrioid Well- and Poorly-Differentiated Tumours and Endometrioid and Serous Subtypes of Endometrial Cancers. Kalinkova L; Kajo K; Karhanek M; Wachsmannova L; Suran P; Zmetakova I; Fridrichova I Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842533 [TBL] [Abstract][Full Text] [Related]
52. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium. Soufla G; Sifakis S; Spandidos DA Cancer Lett; 2008 Feb; 259(2):146-55. PubMed ID: 18006148 [TBL] [Abstract][Full Text] [Related]
53. Expression of the epidermal growth factor system in endometrioid endometrial cancer. Ejskjaer K; Sørensen BS; Poulsen SS; Forman A; Nexø E; Mogensen O Gynecol Oncol; 2007 Jan; 104(1):158-67. PubMed ID: 16962163 [TBL] [Abstract][Full Text] [Related]
54. The pattern of CD98 expression is different between uterine serous papillary carcinoma and endometrioid endometrial carcinoma. Monaghan H; Williams AR Gynecol Oncol; 2007 Jan; 104(1):264-5. PubMed ID: 17092549 [No Abstract] [Full Text] [Related]
55. Array comparative genomic hybridization analysis indicates that serous carcinomas of the ovary, fallopian tube and endometrium are distinct entities. Nowee ME; Seeber LM; Horrée N; Snijders AM; Van Diest PJ; Verheijen RH; Dorsman JC Histopathology; 2010 Oct; 57(4):634-7. PubMed ID: 20955390 [No Abstract] [Full Text] [Related]
57. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038 [TBL] [Abstract][Full Text] [Related]
58. Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer. Sawiris GP; Sherman-Baust CA; Becker KG; Cheadle C; Teichberg D; Morin PJ Cancer Res; 2002 May; 62(10):2923-8. PubMed ID: 12019173 [TBL] [Abstract][Full Text] [Related]